Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

Figure 3

Kaplan-Meier plot showing the DFS (A) and OS (B) of TIMP-1 low and high CMF-treated patients. The median TIMP-1 concentration of the total patient group (12.5 ng/mg of total protein) was used as cut point (TIMP-1 low patients N = 172, TIMP-1 high patients N = 152). Cox univariate regression analysis; DFS: HR 1.15, 95% CI 0.82-0.1.61, P = 0.42; OS: HR, 1.44 (0.91-2.29), P = 0.12.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us